May 08, 2024 / 11:30AM GMT
Sijmen de Vries - Pharming Group NV - Chief Executive Officer, Executive Director
Welcome, ladies and gentlemen, to this first-quarter results conference. I'm here with my -- next slide, please -- I'm here with my three colleagues in order of speaking, Stephen Toor, our Chief Commercial Officer, who is joining us from our New Jersey office; Dr. Anurag Relan, our Chief Medical Officer, joining us from our US office as well; and Jeroen Wakkerman, our Chief Financial Officer, who is based with me here in Leiden.
Before I do that, I would like to point out to next slide, please, number three, that is the forward-looking statement slide. So we will be making forward-looking statements today in our presentation, and those are based upon our current plans and your insights of the -- and situations of the current market circumstances. And of course, actual results may differ from these forward-looking statements. So you cannot necessarily rely on those.
So having said that, I would like to go to slide number 4 and maybe even onwards to slide number 5, because you have seen my picture already.
Q1 2024 Pharming Group NV Earnings Call Transcript
May 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers